LGT Group Foundation’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,248
Closed -$364K 293
2025
Q1
$364K Hold
3,248
0.01% 240
2024
Q4
$300K Sell
3,248
-18,481
-85% -$1.66M ﹤0.01% 246
2024
Q3
$1.84M Sell
21,729
-3,965
-15% -$303K 0.03% 187
2024
Q2
$1.76M Sell
25,694
-1,710
-6% -$114K 0.03% 183
2024
Q1
$2.01M Sell
27,404
-2,138
-7% -$164K 0.05% 169
2023
Q4
$2.4M Sell
29,542
-2,320
-7% -$181K 0.05% 174
2023
Q3
$2.36M Buy
31,862
+1,430
+5% +$110K 0.06% 170
2023
Q2
$2.35M Sell
30,432
-3,823
-11% -$305K 0.06% 184
2023
Q1
$2.84M Sell
34,255
-47,668
-58% -$3.95M 0.08% 179
2022
Q4
$7.03M Sell
81,923
-32,412
-28% -$2.57M 0.22% 107
2022
Q3
$7.05M Buy
114,335
+279
+0.2% +$17.6K 0.27% 88
2022
Q2
$7.05M Buy
114,056
+6,569
+6% +$407K 0.21% 97
2022
Q1
$6.41M Buy
107,487
+38,810
+57% +$2.48M 0.15% 120
2021
Q4
$4.99M Buy
+68,677
New +$4.73M 0.13% 122

Other funds holding GILD

LGT Group Foundation's GILD Position: Q2 2025 in Review

LGT Group Foundation sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 3,248 shares — an estimated $364K sold.

LGT Group Foundation first reported a position in GILD in Q4 2021 and held it in 14 quarters. The position peaked at $7.05M in Q3 2022. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • LGT Group Foundation reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • LGT Group Foundation sold 3,248 Gilead Sciences shares in Q2 2025, an estimated $364K.
  • LGT Group Foundation first reported a position in Gilead Sciences in Q4 2021 and held it in 14 quarters.
  • LGT Group Foundation's Gilead Sciences position peaked at $7.05M in Q3 2022.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on LGT Group Foundation's 13F filing for Q2 2025, filed 22 Jul 2025.